SG11202109032SA - Compounds for treating and preventing net associated complications - Google Patents

Compounds for treating and preventing net associated complications

Info

Publication number
SG11202109032SA
SG11202109032SA SG11202109032SA SG11202109032SA SG11202109032SA SG 11202109032S A SG11202109032S A SG 11202109032SA SG 11202109032S A SG11202109032S A SG 11202109032SA SG 11202109032S A SG11202109032S A SG 11202109032SA SG 11202109032S A SG11202109032S A SG 11202109032SA
Authority
SG
Singapore
Prior art keywords
treating
compounds
associated complications
preventing net
net associated
Prior art date
Application number
SG11202109032SA
Inventor
Christopher Parish
Connor O'meara
Lucy Coupland
Benjamin Ju Chye Quah
Farzaneh Kordbacheh
Anna Bezos
Anna Browne
Ross Stephens
Gregory David Tredwell
Lee Andrew Philip
Karen Knox
Itzstein Laurence Mark Von
Chih-Wei Chang
Anne Brüstle
David Anak Simon Davis
Original Assignee
Univ Australian National
Univ Griffith
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Australian National, Univ Griffith filed Critical Univ Australian National
Publication of SG11202109032SA publication Critical patent/SG11202109032SA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG11202109032SA 2019-02-25 2019-02-25 Compounds for treating and preventing net associated complications SG11202109032SA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/AU2019/050156 WO2020172698A1 (en) 2019-02-25 2019-02-25 Compounds for treating and preventing net associated complications

Publications (1)

Publication Number Publication Date
SG11202109032SA true SG11202109032SA (en) 2021-09-29

Family

ID=72238229

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202109032SA SG11202109032SA (en) 2019-02-25 2019-02-25 Compounds for treating and preventing net associated complications

Country Status (12)

Country Link
US (1) US20220168327A1 (en)
EP (1) EP3930726A4 (en)
JP (1) JP2022530732A (en)
KR (1) KR20210132032A (en)
CN (1) CN113473992A (en)
AU (1) AU2019431212A1 (en)
BR (1) BR112021016812A2 (en)
CA (1) CA3130405A1 (en)
EA (1) EA202192345A1 (en)
IL (1) IL285828A (en)
SG (1) SG11202109032SA (en)
WO (1) WO2020172698A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022116981A1 (en) * 2020-12-01 2022-06-09 远大医药（中国）有限公司 Application of polyanionic cellobioside compound

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2159649A1 (en) * 1993-03-29 1994-10-13 Queen's University At Kingston Anticoagulant compounds
EP1614416A3 (en) * 1993-03-29 2009-07-01 BELLUS Health (International) Limited Method for treating amyloidosis
JPH09183789A (en) * 1995-10-31 1997-07-15 Sanwa Kagaku Kenkyusho Co Ltd New sulfated and phosphated sugar derivative, its production and use
EP1699806A1 (en) * 2003-12-23 2006-09-13 Progen Industries Limited Glycosaminoglycan (gag) mimetics
AU2005219456B2 (en) * 2004-03-04 2011-04-07 Progen Pharmaceuticals Limited Sulfated oligosaccharide derivatives
KR101956335B1 (en) * 2010-12-01 2019-03-08 디 오스트레일리언 내셔널 유니버시티 Histone inhibition
BR112020013714A2 (en) * 2017-12-15 2020-12-01 The Australian National University compounds for the treatment and prevention of pathologies mediated by extracellular histone
WO2022116981A1 (en) * 2020-12-01 2022-06-09 远大医药（中国）有限公司 Application of polyanionic cellobioside compound

Also Published As

Publication number Publication date
IL285828A (en) 2021-10-31
WO2020172698A1 (en) 2020-09-03
AU2019431212A1 (en) 2021-09-16
CA3130405A1 (en) 2020-09-03
JP2022530732A (en) 2022-07-01
US20220168327A1 (en) 2022-06-02
KR20210132032A (en) 2021-11-03
BR112021016812A2 (en) 2021-11-16
CN113473992A (en) 2021-10-01
EP3930726A4 (en) 2022-10-05
EA202192345A1 (en) 2021-12-06
EP3930726A1 (en) 2022-01-05

Similar Documents

Publication Publication Date Title
ZA202006627B (en) Methods and compositions for treating cancer
IL285496A (en) Methods for treating cholestasis
IL282600A (en) Composition and method for treating the lungs
IL283042A (en) Compounds and compositions for treating conditions associated with nlrp activity
IL288914A (en) Compositions and methods for treating cancer
IL286350A (en) Compositions and methods for treating cancer
ZA202207394B (en) Compositions and methods for treating hemoglobinopathies
IL280413A (en) Bismuth-thiol compositions and methods for treating wounds
IL285734A (en) Devices and methods for treating edema
ZA202104870B (en) Methods and compositions for treating cancer
IL290920A (en) Methods and compositions for treating a disease or disorder
IL285886A (en) Compositions and methods for treating laminopathies
SG11202012055PA (en) Methods and compositions for preventing or treating calciphylaxis
SG11202012435UA (en) Compositions and methods for treating cancer
IL287982A (en) Compositions and methods for treating cancer
IL288086A (en) Methods and materials for treating cancer
IL290770A (en) Compounds and methods for treating oxalate-related diseases
IL285796A (en) Methods and compositions for treating
IL286153A (en) Methods and compositions for treating cancer
IL285828A (en) Compounds for treating and preventing net associated complications
PL3810128T3 (en) Compositions for treating and/or preventing protein-aggregation diseases
SG11202010911WA (en) Methods and compositions for treating chronic urticaria
IL291609A (en) Methods for treating acute wounds and improving outcomes
IL285036A (en) Methods and compositions for treating cancer
IL282948A (en) Compositions and methods for treating cancer